← Eichor
Study identifier: NCT02914808 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Oedema Study : Chroedem

Condition: Lower Limb Chronic Oedema  ·  Sponsor: University Hospital, Montpellier

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The chroedem study is aiming to assess tissue and biomolecular components of chronic lower limb oedema (CO). The investigators working hypothesis is that according to the aetiology of CO, the proportion of oedema \& composition of peri-oedema tissues (fat, muscle, fibrosis/inflammation) might differ and could at least in part explain differences in failure/success of compressive therapies from one patient to another. For that purpose, 24 patients with a post-thrombotic syndrome (PTS)-related oedema and 24 patients with a primary lymphedema will undergo a magnetic resonance imaging (MRI)) of the legs and biological (genetic) testing.

This description comes directly from the study's public registry record.

Talk to the study team

ISABELLE QUERE, MD, PhD  ·  (0)4 67 33 70 25  ·  i-quere@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (3)

Pr Sophie BLAISEGrenoble, Isère, FranceNot Yet Recruiting
University Hospital of MontpellierMontpellier, FranceRecruiting
University Hospital NimesNîmes, FranceNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02914808